Targagenix

By GREGORY ZELLER // A biotech manufacturer with a 23-year history of servicing Stony Brook University researchers and startups is being evicted from the university’s Chemistry Building – and nobody seems entirely sure why. Chem-Master International, a producer of unique chemical compounds for research and commercial development, has operated inside the Chemistry Building since it launched in 1994, thanks to a “revocable permit” – special SUNY dispensation allowing nontraditional programs and outside entities to occupy…

By GREGORY ZELLER // Several breakout research projects – and a few familiar faces from the cutting edge – scored funding this week through Stony Brook University’s annual biotechnology awards program. The Center for Biotechnology at SBU, an Empire State Development Division of Science, Technology and Innovation Center for Advanced Technology, has announced the recipients of the 2017-18 Applied Research and Development awards. The awards, along with matching funds from the recipients and other stakeholders,…

By GREGORY ZELLER // Many have said them, tried their best and fallen short – but the words still have unique and powerful meaning, in medical parlance and beyond. A cure for cancer. James Egan doesn’t say that, specifically. But the “former mad scientist” – he does say that – and his team at Targagenix Inc., a 2013 startup residing inside Stony Brook University’s Long Island High-Technology Incubator, are developing a drug that’s unique in…